General Information of DTT (ID: TTABNSJ)

DTT Name Pyruvate kinase (PK) DTT Info
Gene Name PK

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Etavopivat DMXOHYH Sickle-cell disorder 3A51 Phase 2/3 [1]
AGS-348 DMDUIO4 Hereditary angioedema 4A00.14 Phase 1 [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease. J Pharmacol Exp Ther. 2022 Mar;380(3):210-219.
2 Clinical pipeline report, company report or official report of Agios Pharmaceuticals.